Summary:
The Indian Council of Medical Research (ICMR) has recommended anti-malaria drug hydroxychloroquine for health workers and family members of coronavirus patients who are at high risk. The recommendation is mainly for asymptomatic people who are closely working with COVID-19 patients. Chloroquine — which is normally used to prevent and treat malaria — was administered via drug Plaquenil. Two towns in the protocol, Nice and Avignon, gave us infected patients who had not yet received treatment,” Raoult was quoted as saying by connexionfrance.com. Chloroquine phosphate and hydroxychloroquine have previously been used to treat coronavirus patients in China, in ongoing COVID-19 clinical trials..